These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Rules to carry out hepatic arterial infusion chemotherapy at home for patients with liver metastasis of colorectal cancer].
    Author: Takahashi K, Mori T, Yamaguchi T, Honma S, Arai K, Iwasaki Y, Kimura Y.
    Journal: Gan To Kagaku Ryoho; 2002 Dec; 29 Suppl 3():480-3. PubMed ID: 12536834.
    Abstract:
    We analyzed the effectiveness and adverse effects of hepatic arterial infusion chemotherapy (HAI) for patients with liver metastasis of colorectal cancer in order to clarify the rules of HAI. We provided HAI to 72 patients after hepatic resection and to 119 patients with unresectable liver metastases. The preventive effect on hepatic recurrence was recognized in the group administered more than 15 g of 5-FU (total dose). The response rate of patients with unresectable metastases was 60.3%. Adverse effects were observed in 65.8% of the patients. It is important to establish a follow-up system in each hospital to treat the patients as soon as possible when patients develop an adverse reaction.
    [Abstract] [Full Text] [Related] [New Search]